Biologics Introduces Clinical Policy and Therapeutic Intelligence Office
Wednesday, May 01, 2013
Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office.
Oxford BioMedica Announces Novartis Collaboration
Wednesday, May 01, 2013
Oxford BioMedica plc announces that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology.
ProMetic and Sartorius Stedim Biotech Join Forces
Wednesday, May 01, 2013
ProMetic BioProduction's plasma purification facility to become the technological showroom for Plasma Protein Purification System, SSB to contribute equipment and consumables.
Boehringer Ingelheim Announces Growth for Financial Year 2012
Tuesday, April 30, 2013
Net sales rose by 11.5 percent to around €14.7 billion and sales of PRADAXA® exceeded €1 billion.
Catalent Biologics Opens New Single-Use Biomanufacturing Center of Excellence
Tuesday, April 30, 2013
State-of-the-art cGMP facility quadruples biomanufacturing capacity, extensively utilizes single-use technology for greater flexibility and efficiency.
OPKO Health to Acquire PROLOR Biotech
Tuesday, April 30, 2013
Acquisition adds promising late stage product hGH-CTP targeting growth hormone deficiency and preclinical products targeting hemophilia, obesity & diabetes.
NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage Trial
Monday, April 29, 2013
The trial results appeared in the April 1 issue of the Journal of Infectious Diseases.
Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License
Monday, April 29, 2013
Agreement grants Batavia Bioservices the exclusive rights to STEP™ technology developed by scientists at CellaGenics BV, an UvA Holding BV company.
OBT and Boehringer Ingelheim Enter Collaboration
Monday, April 29, 2013
Collaboration to discover novel antibody targets in cancer.
|
|
|
|
|
|
